Immunic Therapeutics

Share on: 
Business Area(s): 
Description: 

Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including relapsing-remitting multiple sclerosis, ulcerative colitis, Crohn’s disease, and psoriasis.

Career Page(s): 
Location(s): 
New York NY
United States
Planegg-Martinsried
Germany